Hugo Stephenson

Hugo Stephenson is a seasoned entrepreneur and executive with extensive experience in the healthcare and technology sectors. He is currently the Co-Founder and Executive Chair of TrialScreen, a position he has held since May 2024.1 In this role, Stephenson aims to improve patient centricity in clinical trial designs and help deliver personalized and life-changing therapies.1

Career Highlights

Recent Ventures::

• Co-Founder and Executive Chair of TrialScreen (May 2024 - Present)1
• Founder and CEO of MedNotes.ai (April 2024 - Present)1

Previous Roles::

• Founder and Executive Director at Induction Healthcare Group PLC (May 2018 - March 2023)1
• Co-CEO at Induction Healthcare Group PLC (April 2020 - August 2021)1
• Senior Vice President of Strategic Research & Safety at Quintiles Transnational (April 2003 - April 2007)1
• Founder of Health Research Solutions (March 1999 - September 2002)1
• Co-Founder of MedSeed (1998 - 1999)1

Entrepreneurial Activities

Stephenson has been an active investor since September 2011, focusing on "smaller things that will become big things soon enough".1 His recent acquisitions include Opin.AI, a leading Asia/Pacific patient recruitment technology and service firm, which he integrated into TrialScreen.13

Expertise and Interests

Hugo Stephenson's expertise spans various areas within healthcare and technology:

• Clinical trial design and patient recruitment
• Healthcare IT and decision support software
• Late phase and real-world evidence in pharmaceutical research
• Drug safety operations
• Remote indigenous education (through involvement with Studio Schools of Australia)2

Throughout his career, Stephenson has demonstrated a commitment to innovation in healthcare, particularly in improving clinical trials and leveraging technology to enhance patient care and research outcomes.